| Literature DB >> 27926589 |
Lara Grau-López1, Constanza Daigre, Nestor Mercado, Miquel Casas, Carlos Roncero.
Abstract
Few studies have described movement disorders as withdrawal symptoms during psychostimulant detoxification. Although dystonia has been reported as an uncommon adverse effect of methylphenidate treatment, it has not been described in the context of methylphenidate withdrawal. We report a case of dystonia as the main withdrawal symptom in a methylphenidate-dependent adult participating in an inpatient methylphenidate detoxification program. Although movement disorders such as dystonia are very rare adverse effects of methylphenidate withdrawal, practitioners need to be alert to this risk in order to initiate appropriate treatment.Entities:
Mesh:
Substances:
Year: 2017 PMID: 27926589 DOI: 10.1097/ADM.0000000000000279
Source DB: PubMed Journal: J Addict Med ISSN: 1932-0620 Impact factor: 3.702